Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8+ T cell-mediated cell death

Jin Hee Kim, Tae Heung Kang, Kyung Hee Noh, Hyun Cheol Bae, Seok Ho Kim, Young Do Yoo, Seung Yong Seong, Tae Woo Kim

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Dendritic cells (DCs) have become an important measure for the treatment of malignancies. Current DC preparations, however, generate short-lived DCs because they are subject to cell death from various apoptotic pressures. Antigen-specific CD8+ cytotoxic T lymphocytes (CTLs) is one of the main obstacles to limit the DC-mediated immune priming since CTLs can recognize the target antigen expressing DCs as target cells and kill the DCs. CTLs secret perforin and serine protease granzymes during CTL killing. Perforin and serine protease granzymes induce the release of a number of mitochondrial pro-apoptotic factors, which are controlled by members of the BCL-2 family, such as BAK, BAX and BIM. FasL linking to Fas on DCs triggers the activation of caspase-8, which eventually leads to mitochondria-mediated apoptosis via truncation of BID. In this study, we tried to enhance the DC priming capacity by prolonging DC survival using anti-apoptotic siRNA targeting these key pro-apoptotic molecules in CTL killing. Human papillomavirus (HPV)-16 E7 antigen presenting DCs that were transfected with these anti-apoptotic siRNAs showed increased resistance to T cell-mediated death, leading to enhanced E7-specific CD8+ T cell activation in vitro and in vivo. Among them, siRNA targeting BIM (siBIM) generated strongest E7-specific E7-specific CD8+ T cell immunity. More importantly, vaccination with E7 presenting DCs transfected with siBIM was capable of generating a marked therapeutic effect in vaccinated mice. Our data indicate that ex vivo manipulation of DCs with siBIM may represent a plausible strategy for enhancing dendritic cell-based vaccine potency.

Original languageEnglish
Pages (from-to)58-67
Number of pages10
JournalImmunology Letters
Volume122
Issue number1
DOIs
Publication statusPublished - 2009 Jan 29

Fingerprint

Vaccine Potency
Apoptosis Regulatory Proteins
Dendritic Cells
Cell Death
T-Lymphocytes
Cytotoxic T-Lymphocytes
Small Interfering RNA
Granzymes
Perforin
Serine Proteases
CD8 Antigens
Human papillomavirus 16
Caspase 8
Therapeutic Uses
Antigen-Presenting Cells

Keywords

  • BIM
  • Dendritic cell
  • HPV E7
  • Immunotherapy
  • Sig/E7/LAMP-1
  • siRNA

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8+ T cell-mediated cell death. / Kim, Jin Hee; Kang, Tae Heung; Noh, Kyung Hee; Bae, Hyun Cheol; Kim, Seok Ho; Yoo, Young Do; Seong, Seung Yong; Kim, Tae Woo.

In: Immunology Letters, Vol. 122, No. 1, 29.01.2009, p. 58-67.

Research output: Contribution to journalArticle

Kim, Jin Hee ; Kang, Tae Heung ; Noh, Kyung Hee ; Bae, Hyun Cheol ; Kim, Seok Ho ; Yoo, Young Do ; Seong, Seung Yong ; Kim, Tae Woo. / Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8+ T cell-mediated cell death. In: Immunology Letters. 2009 ; Vol. 122, No. 1. pp. 58-67.
@article{b23c439477e847be9fe02371b3e7edaa,
title = "Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8+ T cell-mediated cell death",
abstract = "Dendritic cells (DCs) have become an important measure for the treatment of malignancies. Current DC preparations, however, generate short-lived DCs because they are subject to cell death from various apoptotic pressures. Antigen-specific CD8+ cytotoxic T lymphocytes (CTLs) is one of the main obstacles to limit the DC-mediated immune priming since CTLs can recognize the target antigen expressing DCs as target cells and kill the DCs. CTLs secret perforin and serine protease granzymes during CTL killing. Perforin and serine protease granzymes induce the release of a number of mitochondrial pro-apoptotic factors, which are controlled by members of the BCL-2 family, such as BAK, BAX and BIM. FasL linking to Fas on DCs triggers the activation of caspase-8, which eventually leads to mitochondria-mediated apoptosis via truncation of BID. In this study, we tried to enhance the DC priming capacity by prolonging DC survival using anti-apoptotic siRNA targeting these key pro-apoptotic molecules in CTL killing. Human papillomavirus (HPV)-16 E7 antigen presenting DCs that were transfected with these anti-apoptotic siRNAs showed increased resistance to T cell-mediated death, leading to enhanced E7-specific CD8+ T cell activation in vitro and in vivo. Among them, siRNA targeting BIM (siBIM) generated strongest E7-specific E7-specific CD8+ T cell immunity. More importantly, vaccination with E7 presenting DCs transfected with siBIM was capable of generating a marked therapeutic effect in vaccinated mice. Our data indicate that ex vivo manipulation of DCs with siBIM may represent a plausible strategy for enhancing dendritic cell-based vaccine potency.",
keywords = "BIM, Dendritic cell, HPV E7, Immunotherapy, Sig/E7/LAMP-1, siRNA",
author = "Kim, {Jin Hee} and Kang, {Tae Heung} and Noh, {Kyung Hee} and Bae, {Hyun Cheol} and Kim, {Seok Ho} and Yoo, {Young Do} and Seong, {Seung Yong} and Kim, {Tae Woo}",
year = "2009",
month = "1",
day = "29",
doi = "10.1016/j.imlet.2008.12.006",
language = "English",
volume = "122",
pages = "58--67",
journal = "Immunology Letters",
issn = "0165-2478",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8+ T cell-mediated cell death

AU - Kim, Jin Hee

AU - Kang, Tae Heung

AU - Noh, Kyung Hee

AU - Bae, Hyun Cheol

AU - Kim, Seok Ho

AU - Yoo, Young Do

AU - Seong, Seung Yong

AU - Kim, Tae Woo

PY - 2009/1/29

Y1 - 2009/1/29

N2 - Dendritic cells (DCs) have become an important measure for the treatment of malignancies. Current DC preparations, however, generate short-lived DCs because they are subject to cell death from various apoptotic pressures. Antigen-specific CD8+ cytotoxic T lymphocytes (CTLs) is one of the main obstacles to limit the DC-mediated immune priming since CTLs can recognize the target antigen expressing DCs as target cells and kill the DCs. CTLs secret perforin and serine protease granzymes during CTL killing. Perforin and serine protease granzymes induce the release of a number of mitochondrial pro-apoptotic factors, which are controlled by members of the BCL-2 family, such as BAK, BAX and BIM. FasL linking to Fas on DCs triggers the activation of caspase-8, which eventually leads to mitochondria-mediated apoptosis via truncation of BID. In this study, we tried to enhance the DC priming capacity by prolonging DC survival using anti-apoptotic siRNA targeting these key pro-apoptotic molecules in CTL killing. Human papillomavirus (HPV)-16 E7 antigen presenting DCs that were transfected with these anti-apoptotic siRNAs showed increased resistance to T cell-mediated death, leading to enhanced E7-specific CD8+ T cell activation in vitro and in vivo. Among them, siRNA targeting BIM (siBIM) generated strongest E7-specific E7-specific CD8+ T cell immunity. More importantly, vaccination with E7 presenting DCs transfected with siBIM was capable of generating a marked therapeutic effect in vaccinated mice. Our data indicate that ex vivo manipulation of DCs with siBIM may represent a plausible strategy for enhancing dendritic cell-based vaccine potency.

AB - Dendritic cells (DCs) have become an important measure for the treatment of malignancies. Current DC preparations, however, generate short-lived DCs because they are subject to cell death from various apoptotic pressures. Antigen-specific CD8+ cytotoxic T lymphocytes (CTLs) is one of the main obstacles to limit the DC-mediated immune priming since CTLs can recognize the target antigen expressing DCs as target cells and kill the DCs. CTLs secret perforin and serine protease granzymes during CTL killing. Perforin and serine protease granzymes induce the release of a number of mitochondrial pro-apoptotic factors, which are controlled by members of the BCL-2 family, such as BAK, BAX and BIM. FasL linking to Fas on DCs triggers the activation of caspase-8, which eventually leads to mitochondria-mediated apoptosis via truncation of BID. In this study, we tried to enhance the DC priming capacity by prolonging DC survival using anti-apoptotic siRNA targeting these key pro-apoptotic molecules in CTL killing. Human papillomavirus (HPV)-16 E7 antigen presenting DCs that were transfected with these anti-apoptotic siRNAs showed increased resistance to T cell-mediated death, leading to enhanced E7-specific CD8+ T cell activation in vitro and in vivo. Among them, siRNA targeting BIM (siBIM) generated strongest E7-specific E7-specific CD8+ T cell immunity. More importantly, vaccination with E7 presenting DCs transfected with siBIM was capable of generating a marked therapeutic effect in vaccinated mice. Our data indicate that ex vivo manipulation of DCs with siBIM may represent a plausible strategy for enhancing dendritic cell-based vaccine potency.

KW - BIM

KW - Dendritic cell

KW - HPV E7

KW - Immunotherapy

KW - Sig/E7/LAMP-1

KW - siRNA

UR - http://www.scopus.com/inward/record.url?scp=59649107188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59649107188&partnerID=8YFLogxK

U2 - 10.1016/j.imlet.2008.12.006

DO - 10.1016/j.imlet.2008.12.006

M3 - Article

C2 - 19135479

AN - SCOPUS:59649107188

VL - 122

SP - 58

EP - 67

JO - Immunology Letters

JF - Immunology Letters

SN - 0165-2478

IS - 1

ER -